Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04OPJ
|
|||
| Drug Name |
Bicyclo-heptan-2-amine derivative 1
|
|||
| Synonyms |
PMID28051882-Compound-19
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H32N2
|
|||
| Canonical SMILES |
C1CCN(CC1)CCCNC2(CC3CCC2C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C21H32N2/c1-3-8-19(9-4-1)21(17-18-10-11-20(21)16-18)22-12-7-15-23-13-5-2-6-14-23/h1,3-4,8-9,18,20,22H,2,5-7,10-17H2
|
|||
| InChIKey |
XUIHNTYMWPNMJK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
| Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.